2detect crowdfunding campaign

On your marks, get set, go!

Our 2detect crowdfunding campaign ran from the beginning of October until 30.11.2022: Covid or flu? - Reliable and fast treatment with our 2in1 test!  This is especially important for at-risk groups such as people with pre-existing conditions, the elderly and young children. Our LAMP test is faster, cheaper and easier than the gold standard PCR and more reliable than an antigen test. This eases the burden on medical staff and diagnostics. The corona test is already ready; with the donations and our knowledge, it will become a combined test.

2detect was one of six projects in the "ScienceForGood" competition organized by the Fraunhofer-Zukunftsstiftung, which is supporting the project with co-financing and prize money. The decision was made by civil society.

Many thanks to all supporters!

 

 

Crowdfunding Film (german)

 

October 26, 2022 "Das Wissenschaftssofa" from the Fraunhofer IME in Münster

Fever, cough or cold - what's the cause? Prof. Dirk Prüfer and Lena Freund have the solution and have developed a 2-in-1 test that reliably and quickly leads to the right treatment.

In fall and winter, when flu and corona waves coincide, it is difficult to make a diagnosis for the right treatment based on symptoms alone. This is especially important for at-risk populations such as people with pre-existing conditions, the elderly, and children under the age of 5. To be on the safe side, PCR tests are used in such cases, but this method is complex, expensive and time-consuming. A correct and fast result is important for the right treatment. High infection rates can quickly overwhelm medical staff in testing centers and laboratories. As a result, valuable time is lost.

The team led by Prof. Dr. Dirk Prüfer and Lena Freund is therefore researching a 2-in-1 LAMP test that can differentiate between Covid and influenza simultaneously, reliably and quickly.

Our neoLAMP test for the simple and reliable detection of SARS-CoV-2

Researchers in the Department of Functional and Applied Genomics at our Aachen location have developed a neoLAMP test for the rapid and simple detection of potato viruses. The test detects the virus genome directly, as in a PCR.

With the onset of the coronavirus pandemic, it quickly became clear that we could also adapt this test to detect the SARS-CoV-2 virus. No sooner said than done - it works. The benefits are obvious: rapid and reliable diagnosis.